Cathie Wood’s ARK sells Shopify stock, buys Scribe Therapeutics
ARK ETFs sold 17,053 shares of Shopify (SHOP) and bought 199,698 shares of Scribe Therapeutics (SCTX) on October 21st, 2026. Other notable trades included selling Personalize (PSNL) and buying Intuitive Surgical (ISRG) and X-Energy (XE).
How this was made
The 30-second read
Why it matters
These disclosures can move small‑cap stocks and influence sector sentiment, especially for niche biotech and energy names.
Market read
Fund trade disclosures are a timely source for short‑term traders seeking entry points in affected stocks.
What to watch
The trades reflect ARK's thematic rebalancing rather than company‑specific news; investors should consider the broader thematic exposure rather than individual stock moves.
Background
ARK Investment Management regularly publishes daily ETF trade disclosures, providing insight into its thematic allocation shifts.
Ticker impact
ARK bought 199,698 shares of Scribe Therapeutics, indicating fresh bullish interest.
likely support as fund accumulation may attract buyers
ARK's purchase signals confidence; fund inflows often lift price.
ARK sold 18,507 shares of Personalize, suggesting a shift away from the stock.
likely pressure as ARK reduces exposure
Fund selling can trigger short-term sell‑off.
ARK offloaded 17,053 shares of Shopify across two ETFs, continuing a sell trend.
potential downward pressure from fund exit
Repeated sales by a high‑profile manager can influence sentiment.
ARK bought 6,411 shares of Intuitive Surgical, adding to its robotic‑surgery exposure.
likely modest upside as fund buying signals confidence
Fund purchases often precede short‑term price gains.
ARK acquired 200,347 shares of X‑Energy, highlighting interest in innovative energy.
possible support as fund adds exposure
ARK's allocation may attract other investors to the sector.
ARK sold 3,757 shares of Elbit Systems, reducing its exposure.
likely modest pressure from fund exit
Small trade size limits market impact.
ARK bought 42,230 shares of Oklo, indicating new interest in nuclear‑energy tech.
potential upside as fund buying draws attention
ARK's focus on emerging tech can boost investor interest.
ARK sold 494 shares of Amazon, a minor reduction in its holding.
no material price effect expected
Trade size is too small to move a large cap.
Market effects
ARK's activity signals continued bullish stance on biotech, energy innovation, and robotic surgery, while trimming exposure to e‑commerce and certain tech names.
US market, with potential ripple to sector ETFs tracking biotech and energy innovation.
Limited to US‑listed equities; no broader macro or geopolitical effect.
Counterpoint
ARK's sell‑off in Shopify may be premature if e‑commerce fundamentals remain strong; the dip could present a buying opportunity.
Key entities
- PersonCathie Wood
Founder of ARK Invest, whose fund actions drive market attention.
- FirmARK Investment Management
Active manager of thematic ETFs, known for high‑visibility trades.
